Ind-Swift Laboratories Limited Share Price Bombay S.E.
Stocks
INDSWFTLAB
INE915B01019
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 176.45 INR | +4.72% |
|
+8.53% | +100.48% |
| Market Cap | 11.4B 121M 105M 97.12M 91.36M 171M 172M 1.16B 449M 5.62B 454M 444M 19.47B | P/E 2024 |
1.41x | P/E 2025 | 2.38x |
|---|---|---|---|---|---|
| Enterprise Value | 7.13B 75.66M 65.93M 60.77M 57.16M 107M 108M 723M 281M 3.51B 284M 278M 12.18B | EV / Sales 2024 |
0.14x | EV / Sales 2025 | 0.12x |
| Free-Float |
40.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.24% | ||
| 1 week | +7.83% | ||
| Current month | +15.60% | ||
| 1 month | +30.64% | ||
| 3 months | +23.57% | ||
| 6 months | +87.90% | ||
| Current year | +99.17% |
| 1 week | 158.3 |  | 178.65 |
| 1 month | 129.5 | | 178.65 |
| Current year | 88.5 | | 178.65 |
| 1 year | 87 | | 178.65 |
| 3 years | 67.15 | | 186 |
| 5 years | 51.1 | | 186 |
| 10 years | 15.25 | | 186 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 03/01/1995 | |
Himanshu Jain
CEO | Chief Executive Officer | 43 | 14/06/2011 |
Gagan Aggarwal
DFI | Director of Finance/CFO | - | 28/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Himanshu Jain
BRD | Director/Board Member | 43 | - |
| Chairman | 74 | - | |
Rishav Mehta
BRD | Director/Board Member | 35 | 22/03/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.45% | +7.83% | - | - | 149M | |
| +0.55% | +1.31% | +11.16% | +82.81% | 46.28B | |
| -3.14% | +2.84% | +49.62% | +90.59% | 34.73B | |
| +0.27% | -2.19% | -8.42% | +34.39% | 11.56B | |
| +0.22% | -2.72% | +13.11% | +93.92% | 11.32B | |
| -0.57% | +2.14% | +38.16% | +129.26% | 9.27B | |
| -1.02% | +0.26% | +12.20% | +39.05% | 7.13B | |
| -1.67% | +1.13% | +43.06% | -18.68% | 6.6B | |
| +0.12% | -0.75% | +31.63% | +236.91% | 6.39B | |
| +0.73% | -2.44% | -37.77% | -7.15% | 4.98B | |
| Average | -0.07% | -0.19% | +16.97% | +75.68% | 15.36B | |
| Weighted average by Cap. | -0.78% | +0.94% | +21.91% | +81.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.97B 138M 120M 111M 104M 195M 196M 1.32B 511M 6.39B 517M 506M 22.16B | 5.62B 59.6M 51.93M 47.87M 45.03M 84.24M 84.83M 570M 221M 2.77B 224M 219M 9.59B |
| Net income | 4.21B 44.67M 38.92M 35.88M 33.74M 63.13M 63.57M 427M 166M 2.07B 168M 164M 7.19B | 2.5B 26.58M 23.16M 21.35M 20.08M 37.56M 37.83M 254M 98.63M 1.23B 99.76M 97.62M 4.28B |
| Net Debt | -4.15B -44.07M -38.39M -35.39M -33.29M -62.28M -62.72M -421M -164M -2.05B -165M -162M -7.09B | -4.27B -45.26M -39.43M -36.35M -34.19M -63.97M -64.42M -432M -168M -2.1B -170M -166M -7.29B |
Employees
1,246
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 176.45 ₹ | +4.72% | 81,331 |
| 18/06/26 | 168.50 ₹ | +3.69% | 114,686 |
| 17/06/26 | 162.50 ₹ | -0.21% | 33,940 |
| 16/06/26 | 162.85 ₹ | +0.68% | 37,697 |
| 15/06/26 | 161.75 ₹ | -0.71% | 47,632 |
- Stock Market
- Stocks
- INDSWFTLAB Stock
- INDSWFTLAB Stock
Select your edition
All financial news and data tailored to specific country editions
